What obesity drugmakers see next in the market: More pills, easier access and drug combinations (2026-01-23)
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.